Factor | Callens_2015_MicrDrugResi (10258)

10.1089/mdr.2014.0037

Lincomycin-Spectinomycin Use

Swine | Piglets

4

Description

Lincomycin-Spectinomycin Use in Parent Sow

Resistance Outcomes

Resistance Microbe Outcome
Ampicillin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Lincomycin-Spectinomycin Use 56.60 113
No Use 48.70 750
Enrofloxacin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Lincomycin-Spectinomycin Use 19.50 113
No Use 7.50 750
Streptomycin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Lincomycin-Spectinomycin Use 79.60 113
No Use 49.70 750
Sulfadiazine And Trimethoprim
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Lincomycin-Spectinomycin Use 29.20 113
No Use 22.50 750